Form 8-K - Current report:
SEC Accession No. 0001193125-20-236211
Filing Date
2020-08-31
Accepted
2020-08-31 16:00:51
Documents
1
Period of Report
2020-08-25
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d66414d8k.htm 8-K 21909
  Complete submission text file 0001193125-20-236211.txt   23006
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 201151580
SIC: 2834 Pharmaceutical Preparations